Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 4/2003

01-07-2003 | Original Article

Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain—a preliminary report

Authors: W. S. Huang, P. Y. Chiu, A. Kao, C. H. Tsai, C. C. Lee

Published in: Rheumatology International | Issue 4/2003

Login to get access

Abstract

Technetium-99m ethyl cysteinate dimer (Tc-99m ECD) brain single photon emission computed tomography (SPECT) was used to detect abnormal regional cerebral blood flow (rCBF) in 32 female patients with primary Sjögren's syndrome (PSS) showing definite neuropsychiatric symptoms/signs and normal brain magnetic resonance imaging (MRI) findings. It demonstrated hypoperfusion brain lesions in 18 (56.3%) of the patients, most frequently in the parietal lobes, and appears to be a sensitive tool for this clinical application.
Literature
1.
Alexander E (1992) Central nervous system disease in Sjögren's syndrome: new insights into immunopathogenesis. Rheum Dis Clin North Am 18:637–672PubMed
2.
Farnam J, Jorizzo JL, Grant JA, Lavastida MT, Ichikawa Y, Daniels JC (1984) Sjögren's syndrome presenting with hypereosinophilia, lymphopenia and circulating immune complexes. Clin Exp Rheumatol 2:41–46
3.
Fox RI, Howell FV, Bone RC, Michelson P (1984) Primary Sjögren's syndrome: clinical and immunopathological features. Semin Arthritis Rheum 14:77–105PubMed
4.
Sjögren H (1935) Zur Kenntnis der Keratoconjunctivitis Sicca II. Allgemeine Symptomatologie und Ätiologie. Acta Opthalmol (Kbh) 13:1–39
5.
Hietaharju A, Yli-Kerttula U, Hakkinen V, Frey H (1990) Nervous system manifestations in Sjögren's syndrome. Acta Neurol Scand 81:144–152PubMed
6.
Alexander EL, Beall S, Provost TT (1989) Magnetic resonance imaging (MRI) in primary Sjögren's syndrome with central nervous system disease (CNS-SS): new clues to pathogenesis. Arthritis Rheum 29:S63
7.
Manthorpe R, Manthorpe T, Sjoberg S (1992) Magnetic resonance imaging of the brain in patients with primary Sjögren's syndrome. Scand J Rheumatol 21:148–149PubMed
8.
Moutsopoulos HM, Sarmas JH, Talal N (1993) Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? Rheum Dis Clin North Am 19:909–912PubMed
9.
Kao CH, Lan JL, ChangLai SP, Chieng PU (1998) Technetium-99m-HMPAO brain SPECT in Sjögren's syndrome. J Nucl Med 39:773–777PubMed
10.
Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, Volkert WA, Forster AM, Weisner PS, Marriott JA (1987) Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 28:191–202
11.
Juni JE, Waxman AD, Devous MD Sr, Tikofsky RS, Ichise M, Van Heertum RL, Holman BL, Carretta RF, Chen CC (1998) Procedure guideline for brain perfusion SPECT using technetium-99m radiopharmaceuticals. J Nucl Med 39:923–926PubMed
12.
Leveille J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC (1989) Characterization of Tc-99m-L,L-ECD for brain perfusion. Part 2. Biodistribution and brain imaging in humans. J Nucl Med 30:1902–1910PubMed
13.
Asenbaum S, Brucke T, Pirker W, Pietrzyk U, Podreka I (1998) Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. J Nucl Med 39:613–618PubMed
14.
Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H (1997) SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med 38:587–592PubMed
15.
van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB (1996) Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. J Nucl Med 37:1749–1755PubMed
16.
Leveille J, Demonceau G, Walovitch RC (1992) Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 33:480–484PubMed
17.
Kuwabara Y, Ichiya Y, Otsuka M, Tahara T, Fukumura T, Gunasekera R, Masuda K (1990) Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging. Clin Nucl Med 15:893–899
18.
DeVolder AG, Goffinet AM, Bol A, Michel C, de-Barsy T, Laterre C (1990) Brain glucose metabolism in postanoxic syndrome. Positron emission tomographic study. Arch Neurol 47:197–204PubMed
19.
Devinsky O, Petito CK, Alonso DR (1988) Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli and thrombotic thrombocytopenia purpura. Ann Neurol 23:380–384
20.
Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M (1994) Corticosteroid-responsive parkinsonism associated with primary Sjögren's syndrome. Clin Neurol Neurosurg 96:327–331PubMed
21.
Gerraty RP, McKelvie PA, Byrne E (1993) Aseptic meningoencephalitis in primary Sjögren's syndrome. Response to plasmapheresis and absence of CNS vasculitis at autopsy. Acta Neurol Scand 88:309–311PubMed
22.
Berman JL, Kashii S, Trachtman MS, Burde RM (1990) Optic neuropathy and central nervous system disease secondary to Sjögren's syndrome in a child. Ophthalmology 97:1606–1609PubMed
23.
de la Monte SM, Hutchins GM, Gupta PK (1983) Polymorphous meningitis with atypical mononuclear cells in Sjögren's syndrome. Ann Neurol 14:455–461
24.
Alexander EL, Provost TT, Stevens MB, Alexander GE (1982) Neurologic complications of primary Sjögren's syndrome. Medicine 61:247–257
Metadata
Title
Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain—a preliminary report
Authors
W. S. Huang
P. Y. Chiu
A. Kao
C. H. Tsai
C. C. Lee
Publication date
01-07-2003
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2003
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-002-0272-1

Other articles of this Issue 4/2003

Rheumatology International 4/2003 Go to the issue

Case Report

Fatal, gold-induced pneumonitis

Case Report

Unilateral phrenic nerve paralysis in a patient with Wegener's granulomatosis

Case Report

Graves' disease associated with anticardiolipin antibody positivity and acquired protein S deficiency

Original Article

Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman

Case Report

Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis

Original Article

Ileum-targeted steroid therapy in rheumatoid arthritis: double-blind, placebo-controlled trial of controlled-release budesonide

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits